Skip to main content

Keystone Financial Group

Position in EBS — Emergent BioSolutions Inc.

CIK 1729299 LEXINGTON, KY

Position in EBS

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$238,729
-$211 QoQ
Shares Held
28,488
-1.0% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#91
of 193 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Keystone Financial Group holds $2,467,403 across 5 Drug Manufacturers - Specialty & Generic names. EBS ranks #4 (9.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 EBS
Emergent BioSolutions Inc.
This page
28,488 $238,729

All Filings in EBS

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $238,729 28,488
2026-03-31 $238,940 28,788
2025-12-31 $359,527 29,088
2025-09-30 $275,845 31,275
2025-06-30 $193,473 30,325
2025-03-31 $91,003 18,725